financetom
Business
financetom
/
Business
/
BHP set to detail copper growth plans on Chile roadshow, analysts say
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BHP set to detail copper growth plans on Chile roadshow, analysts say
Nov 14, 2024 12:04 AM

MELBOURNE, Nov 14 (Reuters) - BHP Group ( BHP ) is

likely to flesh out plans next week to spend at least $7 billion

over the coming years to recover more metal from the world's

biggest copper mine, Escondida in Chile, investors and analysts

said on Thursday.

The world's biggest listed miner will be hosting analysts

and investors on a roadshow of its Escondida and Spence copper

operations from Nov. 17-20. BHP did not respond to a request for

comment about the presentation.

Copper is key to BHP's growth plans as an essential metal

for the global transition to cleaner energy, but its annual

production is set to fall by around 300,000 metric tons to 1.6

million tons by the end of the decade.

To keep output steady, BHP needs to show how it will extract

more copper from diminishing ore grades at Escondida and justify

higher spending, which it has estimated at between $7 billion

and $12 billion over several years, according to UBS' analysis

of BHP figures.

"The cost to build everything is going up. That's the

reality," said Andy Forster of Argo Investments.

Those costs include a new concentrator at Escondida which

analysts estimate between $5 billion and $6.5 billion alone.

BHP has estimated capital spending including exploration in

the current financial year at $10 billion, rising to $11 billion

on average medium term. It is unclear how much of this Chilean

spend is included in that existing capital spending outlook.

"BHP has made it very public that they are still quite

positive on the long term fundamentals of copper. That does mean

capex and that does mean that we will have to transition to a

period of incentive pricing," said RBC analyst Kaan Peker.

Peker sees copper prices trending up towards $5 a pound or

higher. LME copper last traded at $8,966 a ton ($4 a pound).

There are four main ways to expand copper output in Chile:

replacing the aging Los Colorados concentrator, debottlenecking

its Laguna and Spence concentrators, and applying leaching

technologies to unlock sulphide resources, BHP has said.

Buying Anglo American is "still BHP's best near-term

option for copper," UBS said.

UK takeover laws prevent BHP from making another approach

for Anglo until late this month, after it was rebuffed earlier

this year.

"Anglo is making good progress with its restructuring and is

expected to spin out Amplats after results in Mar/Apr-25. In our

opinion, BHP (and others) are likely to re-evaluate Anglo after

this," UBS said.

BHP has not ruled out a renewed bid.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Etihad in talks for Airbus jets ahead of Dubai Airshow, sources say
Etihad in talks for Airbus jets ahead of Dubai Airshow, sources say
Nov 13, 2025
PARIS, Nov 13 (Reuters) - Abu Dhabi's Etihad is in talks with Airbus to expand its fleet of long-haul jets with a potential order for more A350 aircraft as well as the upgraded A330neo, industry sources said. If a deal is finalised, the order could be announced as soon as next week's Dubai Airshow, the sources added. Etihad, which earlier...
Zura Bio Q3 net loss narrows despite higher R&D costs
Zura Bio Q3 net loss narrows despite higher R&D costs
Nov 13, 2025
Overview * Zura Bio ( ZURA ) Q3 net loss narrows to $20 mln, down from $22.9 mln last year * R&D expenses rise to $11.9 mln in Q3, reflecting tibulizumab trial advancement Outlook * Zura Bio expects topline data from tibulizumab trials in H2 2026 * Company anticipates cash to fund operations through 2027 * Zura Bio ( ZURA...
DarioHealth misses Q3 revenue estimates
DarioHealth misses Q3 revenue estimates
Nov 13, 2025
Overview * DarioHealth Q3 2025 revenue declined year-over-year, missing analyst expectations * Net income for Q3 2025 beat analyst estimates despite revenue decline * Operating income for Q3 2025 missed analyst expectations Outlook * Dario targets $12.4 mln in new business for 2025 * Company expects to reach cashflow breakeven by late 2026 to early 2027 * Dario's 2026 commercial...
Biotech Immunic's Q3 net loss widens
Biotech Immunic's Q3 net loss widens
Nov 13, 2025
Overview * Immunic ( IMUX ) reports Q3 net loss of $25.6 mln, with insufficient cash for 12 months * R&D expenses decreased by $1.4 mln in Q3 2025 compared to Q3 2024 Outlook * Company expects top-line data from phase 3 ENSURE trials by end of 2026 * Company preparing further clinical testing of IMU-856, contingent on financing Result...
Copyright 2023-2026 - www.financetom.com All Rights Reserved